documents: FDA-2022-N-2826-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-2826-0001 FDA FDA-2022-N-2826 Allergan Sales, LLC, et al.; Withdrawal of Approval of 10 Abbreviated New Drug Applications Notice Withdrawal 2022-11-21T05:00:00Z 2022 11 2022-11-21T05:00:00Z   2022-11-21T13:23:13Z 2022-25315 0 0 09000064854f814f

Links from other tables